Mattia Algeri
0000-0002-6673-2664
Publication & Citation Trends
Most Cited Works
Publications
105 total
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
Cited by 50
OpenAlex
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia PDF
Cited by 112
OpenAlex
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study PDF
Cited by 57
OpenAlex
Betibeglogene Autotemcel Gene Therapy for Non–β <sup>0</sup> /β <sup>0</sup> Genotype β-Thalassemia PDF
Cited by 246
OpenAlex
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies PDF
Cited by 66
OpenAlex
TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders PDF
Cited by 55
OpenAlex
Research Topics
Hematopoietic Stem Cell Transplantation
(46)
CAR-T cell therapy research
(32)
Immune Cell Function and Interaction
(23)
Acute Lymphoblastic Leukemia research
(21)
Acute Myeloid Leukemia Research
(13)
Frequent Co-Authors
Affiliations
Università Cattolica del Sacro Cuore
Cornell University
University of Pavia
Ministero della Salute
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico